TORRANCE, Calif., May 9, 2013 –Timothy Coté, M.D., MPH, former director of the Office of Orphan Product Development of the U.S. Food and Drug Administration, has joined Emmaus Medical, Inc., a specialty pharmaceutical and regenerative medicine company, in an advisory capacity, the company announced today. Dr. Coté will advise Emmaus on the regulatory pathway for the company’s sickle cell disease treatment.